134 related articles for article (PubMed ID: 1871829)
1. The role of immunoglobulin in bone marrow transplantation.
Saral R
Transplant Proc; 1991 Aug; 23(4):2128-32. PubMed ID: 1871829
[TBL] [Abstract][Full Text] [Related]
2. Intravenous immunoglobulin and CMV-seronegative blood products for prevention of CMV infection and disease in bone marrow transplant recipients.
Winston DJ; Ho WG; Bartoni K; Champlin RE
Bone Marrow Transplant; 1993 Sep; 12(3):283-8. PubMed ID: 8241988
[TBL] [Abstract][Full Text] [Related]
3. A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation.
Winston DJ; Antin JH; Wolff SN; Bierer BE; Small T; Miller KB; Linker C; Kaizer H; Lazarus HM; Petersen FB; Cowan MJ; Ho WG; Wingard JR; Schiller GJ; Territo MC; Jiao J; Petrarca MA; Tonetta SA
Bone Marrow Transplant; 2001 Jul; 28(2):187-96. PubMed ID: 11509937
[TBL] [Abstract][Full Text] [Related]
4. Immune globulin therapy in allogeneic bone marrow transplant: a critical review.
Guglielmo BJ; Wong-Beringer A; Linker CA
Bone Marrow Transplant; 1994 May; 13(5):499-510. PubMed ID: 8054903
[TBL] [Abstract][Full Text] [Related]
5. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
6. Bedside leukoreduction of cellular blood components in preventing cytomegalovirus transmission in allogeneic bone marrow transplant recipients: a retrospective study.
Narvios AB; Lichtiger B
Haematologica; 2001 Jul; 86(7):749-52. PubMed ID: 11454531
[TBL] [Abstract][Full Text] [Related]
7. [Infections following bone marrow transplantation].
Ljungman P; Andersson J; Sparrelid E
Nord Med; 1995; 110(12):320-1. PubMed ID: 8524635
[TBL] [Abstract][Full Text] [Related]
8. A comparison of postengraftment infectious morbidity and mortality after allogeneic partially T cell-depleted peripheral blood progenitor cell transplantation versus T cell-depleted bone marrow transplantation.
Broers AE; van der Holt B; Haze S; Braakman E; Gratama JW; Löwenberg B; Cornelissen JJ
Exp Hematol; 2005 Aug; 33(8):912-9. PubMed ID: 16038784
[TBL] [Abstract][Full Text] [Related]
9. Cytomegalovirus infection after bone marrow transplantation in children.
Castagnola E; Cappelli B; Erba D; Rabagliati A; Lanino E; Dini G
Hum Immunol; 2004 May; 65(5):416-22. PubMed ID: 15172440
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation.
Sullivan KM; Kopecky KJ; Jocom J; Fisher L; Buckner CD; Meyers JD; Counts GW; Bowden RA; Peterson FB; Witherspoon RP
N Engl J Med; 1990 Sep; 323(11):705-12. PubMed ID: 2167452
[TBL] [Abstract][Full Text] [Related]
11. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
12. [Intravenous immunoglobulins in bone marrow transplantation].
Andolina M; Giorgi R; Maximova N; Comar M
Pediatr Med Chir; 1993; 15(4):347-8. PubMed ID: 8265452
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow transplantation for chronic myelogenous leukemia: clinical outcomes.
Enright H; Davies S; McGlave P
Clin Transpl; 1994; ():283-93. PubMed ID: 7547549
[TBL] [Abstract][Full Text] [Related]
14. Treatment of severe cytomegalovirus infection with ganciclovir and high-dose intravenous immunoglobulin in patients with allogeneic bone marrow transplants. A pilot study.
Lehn P; Quessar A; Devergie A; Esperou-Bourdeau H; Traineau R; Trédaniel J; Benbunan M; Bussel A; Jolivet I; Mazeron MC
Nouv Rev Fr Hematol (1978); 1990; 32(1):17-20. PubMed ID: 2161510
[TBL] [Abstract][Full Text] [Related]
15. Comparison of two doses of intravenous immunoglobulin after allogeneic bone marrow transplants.
Abdel-Mageed A; Graham-Pole J; Del Rosario ML; Longmate J; Ochoa S; Amylon M; Elfenbein GJ; Janiec J; Jansen J; Lazarus HM
Bone Marrow Transplant; 1999 May; 23(9):929-32. PubMed ID: 10338049
[TBL] [Abstract][Full Text] [Related]
16. Preemptive ganciclovir administration based solely on asymptomatic pulmonary cytomegalovirus infection in allogeneic bone marrow transplant recipients: long-term follow-up.
Zaia JA; Schmidt GM; Chao NJ; Rizk NW; Nademanee AP; Niland JC; Horak DA; Lee J; Gallez-Hawkins G; Kusnierz-Glaz CR
Biol Blood Marrow Transplant; 1995 Dec; 1(2):88-93. PubMed ID: 9118297
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic bone marrow transplantation: relation between chimaerism and immunity.
Vossen J
Verh K Acad Geneeskd Belg; 1998; 60(2):111-43; discussion 143-5. PubMed ID: 9703764
[TBL] [Abstract][Full Text] [Related]
18. Infections in allogeneic bone marrow transplant recipients.
Wingard JR
Semin Oncol; 1993 Oct; 20(5 Suppl 6):80-7. PubMed ID: 8211220
[TBL] [Abstract][Full Text] [Related]
19. [Immunoglobulin therapy in patients after autologous and allogeneic bone marrow transplantation].
Körholz D; Grünewald S; Burdach S; Göbel U
Infusionsther Transfusionsmed; 1993 Apr; 20 Suppl 1():68-71; discussion 72. PubMed ID: 8499754
[TBL] [Abstract][Full Text] [Related]
20. A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections.
Anderson D; DeFor T; Burns L; McGlave P; Miller J; Wagner J; Weisdorf D
Biol Blood Marrow Transplant; 2003 Jan; 9(1):52-9. PubMed ID: 12533742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]